Bain Capital Life Sciences Fund L.P. 13D and 13G filings for Pharvaris N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:30 pm Sale | 2025-12-31 | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 1,640,817 2.500% | -226,812 (-12.14%) | Filing |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 1,867,629 3.000% | -99,464 (-5.06%) | Filing |
| 2024-01-22 4:30 pm Sale | 2024-01-18 | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 1,967,093 3.800% | -918,173 (-31.82%) | Filing |
| 2023-06-23 4:34 pm Unchanged | 2023-06-21 | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 7.100% | 0 (Unchanged) | Filing |